A carregar...
Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption
Buprenorphine’s clinical use is approved for the treatment of heroin addiction; however, evidence supporting its efficacy in cocaine abuse also exists. While for heroin it has been demonstrated that the effect of buprenorphine is mediated by its ability to activate μ-opioid peptide receptor (MOP) re...
Na minha lista:
| Publicado no: | Addict Biol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5740020/ https://ncbi.nlm.nih.gov/pubmed/28635181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/adb.12513 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|